WDR11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.057600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.846200E-02
Normal-vs-Stage2
1.456720E-03
Normal-vs-Stage3
4.282200E-02
Normal-vs-Stage4
2.579400E-01
Stage1-vs-Stage2
8.649400E-01
Stage1-vs-Stage3
1.270980E-01
Stage1-vs-Stage4
6.064600E-01
Stage2-vs-Stage3
1.578170E-01
Stage2-vs-Stage4
4.174400E-01
Stage3-vs-Stage4
1.523210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.082110E-03
Normal-vs-AfricanAmerican
7.625500E-02
Normal-vs-Asian
3.000000E-02
Caucasian-vs-AfricanAmerican
8.657200E-01
Caucasian-vs-Asian
7.847400E-01
AfricanAmerican-vs-Asian
9.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.023600E-01
Normal-vs-Female
7.740700E-03
Male-vs-Female
7.301600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.857770E-01
Normal-vs-Age(41-60Yrs)
2.563200E-01
Normal-vs-Age(61-80Yrs)
2.118500E-03
Normal-vs-Age(81-100Yrs)
2.101600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.247000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.355600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.214600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.508400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.599800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.218000E-01
Normal-vs-Daily Drinker
2.918100E-03
Normal-vs-Weekly Drinker
1.090560E-01
Normal-vs-Occasional Drinker
2.480400E-02
Normal-vs-Social Drinker
1.268090E-02
Non Drinker-vs-Daily Drinker
2.642400E-01
Non Drinker-vs-Weekly Drinker
7.704200E-01
Non Drinker-vs-Occasional Drinker
3.208800E-01
Non Drinker-vs-Social Drinker
8.214200E-01
Daily Drinker-vs-Weekly Drinker
3.726000E-01
Daily Drinker-vs-Occasional Drinker
6.691600E-02
Daily Drinker-vs-Social Drinker
2.521600E-01
Weekly Drinker-vs-Occasional Drinker
7.745200E-01
Weekly Drinker-vs-Social Drinker
8.828200E-01
Occasional Drinker-vs-Social Drinker
5.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.386400E-02
Normal-vs-Grade 2
6.383300E-03
Normal-vs-Grade 3
4.157200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.323570E-01
Grade 1-vs-Grade 3
1.130830E-01
Grade 1-vs-Grade 4
5.386400E-02
Grade 2-vs-Grade 3
7.626400E-01
Grade 2-vs-Grade 4
6.383300E-03
Grade 3-vs-Grade 4
4.157200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.888240E-01
Normal-vs-NonDiabetic
1.655300E-03
Diabetic-vs-NonDiabetic
1.485820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.132400E-01
Normal-vs-NoPancreatitis
1.223930E-03
Pancreatitis-vs-NoPancreatitis
8.748600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.177600E-01
Normal-vs-N1
2.262000E-03
N0-vs-N1
7.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.827000E-01
Normal-vs-TP53-NonMutant
2.765000E-01
TP53-Mutant-vs-TP53-NonMutant
8.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
